Source: StartupDelta

Prexton Therapeutics: Lundbeck to Acquire Prexton Therapeutics, for €905M

The post Lundbeck to Acquire Prexton Therapeutics, for €905M appeared first on StartupDelta.

Read full article »
Prexton Therapeutics's Competitors | Prexton Therapeutics's News | Prexton Therapeutics's Financials
Stay up-to-date with the latest news on Prexton Therapeutics
Est. Annual Revenue
$100K-5.0M
Est. Employees
250-500
François Conquet's photo - Founder & CEO of Prexton Therapeutics

Founder & CEO

François Conquet

CEO Approval Rating

75/100

Read more
Stay up-to-date with the latest news on Prexton Therapeutics